Eli Lilly Shares Decline After Co. Reported Revenue Miss
October 23 2019 - 10:54AM
Dow Jones News
By Dave Sebastian
Eli Lilly & Co. (LLY) shares fell about 5% to $104.30
Wednesday after the company earlier in the day reported
third-quarter results.
The pharmaceutical company reported revenue of $5.48 billion,
missing the $5.5 billion analysts polled by FactSet had expected.
The company posted $5.31 billion in revenue a year earlier.
Net income for the quarter was $1.25 billion, or $1.37 a share,
compared with $1.15 billion, or $1.12 a share, in the comparable
quarter last year.
On an adjusted basis, earnings were $1.48 a share, beating the
$1.40 a share analysts polled by FactSet had expected. The company
posted $1.34 a share in adjusted earnings in the year-earlier
period.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
October 23, 2019 10:39 ET (14:39 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Sep 2023 to Sep 2024